Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Cited by (1,606)

Items 501–600 of 1,606

1. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
   Samuel I. A. Cohen, Michele Vendruscolo, Mark Edward Welland, Christopher Martin Dobson, Eugene Michael Terentjev, Tuomas P. J. Knowles · 2011 · The Journal of Chemical Physics
2. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
   Tiffany Ann Thibaudeau, Raymond T. Anderson, David M. Smith · 2018 · Nature Communications
3. Neurodegenerative Diseases: Expanding the Prion Concept
   Walker, Lary C., Jucker, Mathias · 2015 · Annual Review of Neuroscience
4. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
   Arnsten, Amy F. T., Datta, Dibyadeep, Del Tredici, Kelly, Braak, Heiko · 2021 · Alzheimer's & Dementia
5. Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease
   Luc Buée, André Delacourte · 1999 · Brain Pathology
6. Impairments of neural circuit function in Alzheimer's disease
   Busche, Marc Aurel, Konnerth, Arthur · 2016 · Philosophical Transactions of the Royal Society B: Biological Sciences
7. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans
   Uryu, Kunihiro, Chen, Xiao-Han, Martinez, Dan, Browne, Kevin D., Johnson, Victoria E., Graham, David I., Lee, Virginia M.-Y., Trojanowski, John Q., Smith, Douglas H. · 2007 · Experimental Neurology
8. Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease
   Dhaval S. Patel, Stephan N. Witt · 2017 · Oxidative Medicine and Cellular Longevity
9. Tau Aggregation and Its Interplay with Amyloid-β
   Nisbet, Rebecca M., Polanco, Juan-Carlos, Ittner, Lars M., Götz, Jürgen · 2015 · Acta Neuropathologica
10. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
    Salloway, Stephen, Farlow, Martin, McDade, Eric, Clifford, David B., Wang, Guoqiao, Llibre-Guerra, Jorge J., Hitchcock, Janice M., Mills, Susan L., Santacruz, Anna M., Aschenbrenner, Andrew J. et al. · 2021 · Nature Medicine
11. Aβ40 Inhibits Amyloid Deposition<i>In Vivo</i>
    Kim, Jungsu, Onstead, Luisa, Randle, Suzanne, Price, Robert, Smithson, Lisa, Zwizinski, Craig, Dickson, Dennis W., Golde, Todd, McGowan, Eileen · 2007 · The Journal of Neuroscience
12. Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy
    Uchikado, Hirotake, Lin, Wen-Lang, DeLucia, Michael W., Dickson, Dennis W. · 2006 · Journal of Neuropathology and Experimental Neurology
13. Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria
    John, Albin, Reddy, P. Hemachandra · 2021 · Ageing Research Reviews
14. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
    Zelcer, Noam, Khanlou, Negar, Clare, Ryan, Jiang, Qingguang, Reed-Geaghan, Erin G., Landreth, Gary E., Vinters, Harry V., Tontonoz, Peter · 2007 · Proceedings of the National Academy of Sciences
15. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study
    Jack, Clifford R, Wiste, Heather J, Weigand, Stephen D, Rocca, Walter A, Knopman, David S, Mielke, Michelle M, Lowe, Val J, Senjem, Matthew L, Gunter, Jeffrey L, Preboske, Gregory M et al. · 2014 · The Lancet Neurology
16. Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
    Paula M. Canas, Lisiane O. Porciúncula, Geanne M. A. Cunha, Carla G. Silva, Nuno Jesus Machado, Jorge M. A. Oliveira, Catarina Resende Oliveira, Rodrigo Antunes Cunha · 2009 · Journal of Neuroscience
17. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo, Michael J., Devous, Michael D., Navitsky, Michael, Lu, Ming, Salloway, Stephen, Schaerf, Frederick W., Jennings, Danna, Arora, Anupa K., McGeehan, Anne, Lim, Nathaniel C. et al. · 2017 · Brain
18. Phosphorylated tau interactome in the human Alzheimer's disease brain
    Drummond, Eleanor, Pires, Geoffrey, MacMurray, Claire, Askenazi, Manor, Nayak, Shruti, Bourdon, Marie, Safar, Jiri, Ueberheide, Beatrix, Wisniewski, Thomas · 2020 · Brain
19. Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases
    Elisabetta Vegeto, Valeria Benedusi, Adriana C. Maggi · 2008 · Frontiers in Neuroendocrinology
20. Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanism
    Phuong Hoang Nguyen, Mai Suan Li, Gerhard Stock, John E. Straub, Dave Thirumalai · 2006 · Proceedings of the National Academy of Sciences
21. Microglia-Mediated Synapse Loss in Alzheimer's Disease
    Rajendran, Lawrence, Paolicelli, Rosa C. · 2018 · The Journal of Neuroscience
22. Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases
    Tadahiro Numakawa, Haruki Odaka, Naoki Adachi · 2018 · International Journal of Molecular Sciences
23. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior
    Chakrabarty, Paramita, Li, Andrew, Ceballos-Diaz, Carolina, Eddy, James A., Funk, Cory C., Moore, Brenda, DiNunno, Nadia, Rosario, Awilda M., Cruz, Pedro E., Verbeeck, Christophe et al. · 2015 · Neuron
24. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.
    1997 · Europe PMC (PubMed Central)
25. Microglia Function in Central Nervous System Development and Plasticity
    Schafer, Dorothy P., Stevens, Beth · 2015 · Cold Spring Harbor Perspectives in Biology
26. Alzheimer's disease: From immunotherapy to immunoprevention
    Jucker, Mathias, Walker, Lary C. · 2023 · Cell
27. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
    Goode, BL, Feinstein, SC · 1994 · The Journal of cell biology
28. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
    Palmqvist, Sebastian, Insel, Philip S, Stomrud, Erik, Janelidze, Shorena, Zetterberg, Henrik, Brix, Britta, Eichenlaub, Udo, Dage, Jeffrey L, Chai, Xiyun, Blennow, Kaj et al. · 2019 · EMBO Molecular Medicine
29. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
    Kihoon Han, Jimmy Lloyd Holder, Christian Patrick Schaaf, Hui‐Chen Lu, Hongmei Chen, Hyojin Kang, Jianrong Tang, Zhenyu Wu, Shuang Hao, Sau Wai Cheung et al. · 2013 · Nature
30. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
    Gaël Chételat, Renaud La Joie, Nicolas Villain, Audrey Perrotin, Vincent de La Sayette, Francis Eustache, Rik R. Vandenberghe · 2013 · NeuroImage Clinical
31. Loss‐of‐function presenilin mutations in Alzheimer disease
    Bart De Strooper · 2007 · EMBO Reports
32. Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review
    Xin-Hua Zhan, Boryana Stamova, F. Sharp · 2018 · Frontiers in Aging Neuroscience
33. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
    Nils Korte, Ross Nortley, David Attwell · 2020 · Acta Neuropathologica
34. Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
    Witoelar, Aree, Jansen, Iris E., Wang, Yunpeng, Desikan, Rahul S., Gibbs, J. Raphael, Blauwendraat, Cornelis, Thompson, Wesley K., Hernandez, Dena G., Djurovic, Srdjan, Schork, Andrew J. et al. · 2017 · JAMA Neurology
35. Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
    Spangenberg, Elizabeth E., Green, Kim N. · 2017 · Brain, Behavior, and Immunity
36. Can Alzheimer disease be prevented by amyloid-β immunotherapy?
    Lemere, Cynthia A., Masliah, Eliezer · 2010 · Nature Reviews Neurology
37. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
    Tejera, Dario, Mercan, Dilek, Sanchez‐Caro, Juan M, Hanan, Mor, Greenberg, David, Soreq, Hermona, Latz, Eicke, Golenbock, Douglas, Heneka, Michael T · 2019 · The EMBO Journal
38. Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias
    Kelly M. Bakulski, Young Ah Seo, Ruby C. Hickman, Daniel J. Brandt, Harita S. Vadari, Howard Hu, Sung Kyun Park · 2020 · Journal of Alzheimer s Disease
39. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease
    Natalia M. Lyra e Silva, Rafaella Araujo Gonçalves, Tharick Ali Pascoal, Ricardo A. S. Lima‐Filho, Elisa de Paula França Resende, Érica Leandro Marciano Vieira, Antônio Lúcio Teixeira, Leonardo Cruz de Souza, Julyanna A. Peny, Juliana T.S. Fortuna et al. · 2021 · Translational Psychiatry
40. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
    Ekaterina I. Pchitskaya, Попугаева Елена Александровна, Безпрозванный Илья Борисович · 2017 · Cell Calcium
41. Functional and/or structural brain changes in response to resistance exercises and resistance training lead to cognitive improvements – a systematic review
    Herold, Fabian, Törpel, Alexander, Schega, Lutz, Müller, Notger G. · 2019 · European Review of Aging and Physical Activity
42. Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography
    Matthew C. Murphy, John Huston, Clifford R. Jack, Kevin J. Glaser, Armando Manduca, Joel P. Felmlee, Richard L. Ehman · 2011 · Journal of Magnetic Resonance Imaging
43. Microglia Function in Alzheimer’s Disease
    Egle Solito, Magdalena Sastre · 2012 · Frontiers in Pharmacology
44. Tau and neuroinflammation: what impact for Alzheimer's disease and tauopathies?
    Laurent, Cyril, Buée, Luc, Blum, David · 2018 · Biomedical Journal
45. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
    Weiner, Michael W., Veitch, Dallas P., Aisen, Paul S., Beckett, Laurel A., Cairns, Nigel J., Cedarbaum, Jesse, Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William et al. · 2015 · Alzheimer's &amp; Dementia
46. Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
    Doens, Deborah, Fernández, Patricia L · 2014 · Journal of Neuroinflammation
47. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
    Mummery, Catherine J., Börjesson-Hanson, Anne, Blackburn, Daniel J., Vijverberg, Everard G. B., De Deyn, Peter Paul, Ducharme, Simon, Jonsson, Michael, Schneider, Anja, Rinne, Juha O., Ludolph, Albert C. et al. · 2023 · Nature Medicine
48. New Insights Into the Pathogenesis of Alzheimer's Disease
    Liyuan Fan, Cheng-Yuan Mao, Xinchao Hu, Shuo Zhang, Zhi-Hua Yang, Zhengwei Hu, Hui-Fang Sun, Yu Fan, Yali Dong, Jing Yang et al. · 2020 · Frontiers in Neurology
49. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
    Tara E. Tracy, Jesús Madero‐Pérez, Danielle L. Swaney, Timothy S. Chang, Michelle Moritz, Csaba Konràd, Michael Emmerson Ward, Erica J. Stevenson, Ruth Hüttenhain, Grant Kauwe et al. · 2022 · Cell
50. Dementia Resulting From Traumatic Brain Injury: What Is the Pathology?
    Shively, Sharon, Scher, Ann I., Perl, Daniel P., Diaz-Arrastia, Ramon · 2012 · Archives of Neurology
51. Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity
    Tara E. Vanderweyde, Daniel J. Apicco, Katherine Youmans-Kidder, Peter E.A. Ash, Casey N. Cook, Edroaldo Lummertz da Rocha, Karen R. Jansen‐West, Alissa A. Frame, Allison Citro, John Leszyk et al. · 2016 · Cell Reports
52. B cells in autoimmune and neurodegenerative central nervous system diseases
    Joseph J. Sabatino, Anne‐Katrin Pröbstel, Scott S. Zamvil · 2019 · Nature reviews. Neuroscience
53. Axonally Synthesized ATF4 Transmits a Neurodegenerative Signal across Brain Regions
    Jimena Baleriola, Chandler A. Walker, Ying Y. Jean, John F. Crary, Carol M. Troy, Péter L. Nagy, Ulrich Hengst · 2014 · Cell
54. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
    Schaeffer, Véronique, Lavenir, Isabelle, Ozcelik, Sefika, Tolnay, Markus, Winkler, David T., Goedert, Michel · 2012 · Brain
55. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease
    Matthew J. Simon, Jeffrey J. Iliff · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
56. Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease
    Joana A. Loureiro, Stéphanie Andrade, Ana Duarte, Ana Rute Neves, Joana Fontes Queiroz, Cláudia Nunes, Emmanuel Sevin, Laurence Fénart, Fabien Gosselet, Manuel A. N. Coelho et al. · 2017 · Molecules
57. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models
    Dejanovic, Borislav, Wu, Tiffany, Tsai, Ming-Chi, Graykowski, David, Gandham, Vineela D., Rose, Christopher M., Bakalarski, Corey E., Ngu, Hai, Wang, Yuanyuan, Pandey, Shristi et al. · 2022 · Nature Aging
58. Microglial Dynamics and Role in the Healthy and Diseased Brain: A Paradigm of Functional Plasticity
    Gomez-Nicola, Diego, Perry, V. Hugh · 2015 · The Neuroscientist
59. Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice
    Paul T. Jantzen, Karen E. Connor, Giovanni DiCarlo, Gary L. Wenk, John Lawrence Wallace, Amyn M. Rojiani, Domenico Coppola, David Morgan, Marcia N. Gordon · 2002 · Journal of Neuroscience
60. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
    Michael K. Ahlijanian, Nestor X. Barrezueta, Robert D. Williams, Amy B. Jakowski, Kim P. Kowsz, Sheryl A. McCarthy, Timothy Coskran, Anthony A. Carlo, Patricia A. Seymour, John E. Burkhardt et al. · 2000 · Proceedings of the National Academy of Sciences
61. Implications of peptide assemblies in amyloid diseases
    Pu Chun Ke, Marc‐Antoine Sani, Feng Ding, Aleksandr Käkinen, Ibrahim Javed, Frances Separovic, Thomas Paul Davis, Raffaele Mezzenga · 2017 · Chemical Society Reviews
62. Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis
    Uryu, Kunihiro, Laurer, Helmut, McIntosh, Tracy, Praticò, Domenico, Martinez, Daniel, Leight, Susan, Lee, Virginia M.-Y., Trojanowski, John Q. · 2002 · The Journal of Neuroscience
63. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease
    Bai, Bing, Hales, Chadwick M., Chen, Ping-Chung, Gozal, Yair, Dammer, Eric B., Fritz, Jason J., Wang, Xusheng, Xia, Qiangwei, Duong, Duc M., Street, Craig et al. · 2013 · Proceedings of the National Academy of Sciences
64. Repeat motifs of tau bind to the insides of microtubules in the absence of taxol
    Kar, Santwana, Fan, Juan, Smith, Michael J., Goedert, Michel, Amos, Linda A. · 2003 · The EMBO Journal
65. Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
    Jun Wang, Lap Ho, Linghong Chen, Zhong Zhao, Wei Zhao, Xianjuan Qian, Nelson Humala, Ilana Seror, Sadie R. Bartholomew, Clive Rosendorff et al. · 2007 · Journal of Clinical Investigation
66. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
    Christina M. Moloney, Val J. Lowe, Melissa Erin Murray · 2021 · Alzheimer s & Dementia
67. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
    Oksanen, Minna, Petersen, Andrew J., Naumenko, Nikolay, Puttonen, Katja, Lehtonen, Šárka, Gubert Olivé, Max, Shakirzyanova, Anastasia, Leskelä, Stina, Sarajärvi, Timo, Viitanen, Matti et al. · 2017 · Stem Cell Reports
68. In silico study of amyloid β-protein folding and oligomerization
    Brigita Urbanc, Luis Cruz, Sijung Yun, Sergey V. Buldyrev, Gal Bitan, David B. Teplow, Eugene Stanley · 2004 · Proceedings of the National Academy of Sciences
69. Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
    Belfiore, Ramona, Rodin, Alexis, Ferreira, Eric, Velazquez, Ramon, Branca, Caterina, Caccamo, Antonella, Oddo, Salvatore · 2019 · Aging Cell
70. Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
    Baranello, Robert, Bharani, Krishna, Padmaraju, Vasudevaraju, Chopra, Nipun, Lahiri, Debomoy, Greig, Nigel, Pappolla, Miguel, Sambamurti, Kumar · 2015 · Current Alzheimer Research
71. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals
    Schultz, Aaron P., Chhatwal, Jasmeer P., Hedden, Trey, Mormino, Elizabeth C., Hanseeuw, Bernard J., Sepulcre, Jorge, Huijbers, Willem, LaPoint, Molly, Buckley, Rachel F., Johnson, Keith A. et al. · 2017 · The Journal of Neuroscience
72. Circadian rhythms, time-restricted feeding, and healthy aging
    Manoogian, Emily N.C., Panda, Satchidananda · 2017 · Ageing Research Reviews
73. GABA-Receptive Microglia Selectively Sculpt Developing Inhibitory Circuits
    Emilia Favuzzi, Shuhan Huang, Giuseppe-Antonio Saldi, Loïc Binan, Leena Ali Ibrahim, Marian Fernández-Otero, Yuqing Cao, Ayman Zeine, Adwoa Sefah, Karen Zheng et al. · 2020 · Cell
74. Advancing translational research with the Semantic Web
    Alan Ruttenberg, Tim Clark, William Bug, Matthias Samwald, Olivier Bodenreider, Helen Chen, Donald W. Doherty, Kerstin Forsberg, Yong Chao Gao, Vipul Kashyap et al. · 2007 · BMC Bioinformatics
75. Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
    Mormino, Elizabeth C., Betensky, Rebecca A., Hedden, Trey, Schultz, Aaron P., Amariglio, Rebecca E., Rentz, Dorene M., Johnson, Keith A., Sperling, Reisa A. · 2014 · JAMA Neurology
76. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
    the Synaptic Health Endpoints Working Group, Colom-Cadena, Martí, Spires-Jones, Tara, Zetterberg, Henrik, Blennow, Kaj, Caggiano, Anthony, DeKosky, Steven T., Fillit, Howard, Harrison, John E., Schneider, Lon S. et al. · 2020 · Alzheimer's Research &amp; Therapy
77. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci
    Sarah Mizielinska, Tammaryn Lashley, Frances E. Norona, Emma L. Clayton, Charlotte E. Ridler, Pietro Fratta, Adrian M. Isaacs · 2013 · Acta Neuropathologica
78. β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
    Gunnar K. Gouras, Tomas T. Olsson, Oskar Hansson · 2014 · Neurotherapeutics
79. The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
    Steven M. Johnson, Stephen Connelly, Colleen Fearns, Evan T. Powers, Jeffery W. Kelly · 2012 · Journal of Molecular Biology
80. RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
    Ottavio Arancio, Hui Ping Zhang, Xi Chen, Chang Lin, Fabrizio Trinchese, Daniela Puzzo, Shumin Liu, Ashok N. Hegde, Shi Fang Yan, Alan Stern et al. · 2004 · The EMBO Journal
81. Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
    Robert J. Vassar, Peer‐Hendrik Kuhn, Christian Haass, Matthew E Kennedy, Lawrence Rajendran, Philip C. Wong, Stefan F. Lichtenthaler · 2014 · Journal of Neurochemistry
82. Impaired neurogenesis is an early event in the etiology of familial Alzheimer’s disease in transgenic mice
    Demars, Michael, Hu, Yuan‐Shih, Gadadhar, Archana, Lazarov, Orly · 2010 · Journal of Neuroscience Research
83. β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
    Xiaojuan Sun, Weidong Chen, Yan‐Dong Wang · 2015 · Frontiers in Pharmacology
84. Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
    Kim N. Green, Hilda Martínez‐Coria, Hasan Khashwji, Eileen Bailey Hall, Karin Yurko‐Mauro, Lorie Ellis, Frank M. LaFerla · 2007 · Journal of Neuroscience
85. Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
    David Weinshenker · 2018 · Trends in Neurosciences
86. Clinicopathologic and¹¹C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
    Murray, Melissa E., Lowe, Val J., Graff-Radford, Neill R., Liesinger, Amanda M., Cannon, Ashley, Przybelski, Scott A., Rawal, Bhupendra, Parisi, Joseph E., Petersen, Ronald C., Kantarci, Kejal et al. · 2015 · Brain
87. The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
    Xie, Junhua, Van Hoecke, Lien, Vandenbroucke, Roosmarijn E. · 2022 · Frontiers in Immunology
88. Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis
    Scott A. Small, Sam Gandy · 2006 · Neuron
89. Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity
    Kelly S. Kirkley, Katriana A. Popichak, Maryam F. Afzali, Marie E. Legare, Ronald B. Tjalkens · 2017 · Journal of Neuroinflammation
90. The dysregulation of intracellular calcium in Alzheimer disease
    Charlene B Supnet, Безпрозванный Илья Борисович · 2010 · Cell Calcium
91. Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure
    Anant K. Paravastu, Isam M. Qahwash, Richard D. Leapman, Stephen C. Meredith, Robert Tycko · 2009 · Proceedings of the National Academy of Sciences
92. Life Extension Factor Klotho Enhances Cognition
    Dena B. Dubal, Jennifer S. Yokoyama, Lei Zhu, Lauren Broestl, Kurtresha Worden, Dan Wang, Virginia E. Sturm, Daniel Kim, Eric Klein, Gui-Qiu Yu et al. · 2014 · Cell Reports
93. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease
    Boaz Styr, Inna Slutsky · 2018 · Nature Neuroscience
94. Homeostatic and injury‐induced microglia behavior in the aging brain
    Hefendehl, Jasmin K., Neher, Jonas J., Sühs, Rafael B., Kohsaka, Shinichi, Skodras, Angelos, Jucker, Mathias · 2014 · Aging Cell
95. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network
    Harris, Julie A., Devidze, Nino, Verret, Laure, Ho, Kaitlyn, Halabisky, Brian, Thwin, Myo T., Kim, Daniel, Hamto, Patricia, Lo, Iris, Yu, Gui-Qiu et al. · 2010 · Neuron
96. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
    Paul, Justin, Strickland, Sidney, Melchor, Jerry P. · 2007 · The Journal of Experimental Medicine
97. The genetics and neuropathology of Parkinson’s disease
    Henry Houlden, Andrew Singleton · 2012 · Acta Neuropathologica
98. Electrochemistry of Nonconjugated Proteins and Glycoproteins. Toward Sensors for Biomedicine and Glycomics
    Emil Paleček, Jan Tkáč, Martin Bartošík, Tomáš Bertók, Veronika Ostatná, Jan Josef Palecek · 2015 · Chemical Reviews
99. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
    Seyedeh Maryam Alavi Naini, Nadia Soussi‐Yanicostas · 2015 · Oxidative Medicine and Cellular Longevity
100. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
     Zheng, Honghua, Jia, Lin, Liu, Chia-Chen, Rong, Zhouyi, Zhong, Li, Yang, Longyu, Chen, Xiao-Fen, Fryer, John D., Wang, Xin, Zhang, Yun-wu et al. · 2017 · The Journal of Neuroscience